TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.465
-0.305 (-6.39%)
At close: Mar 6, 2026, 4:00 PM EST
4.250
-0.215 (-4.82%)
After-hours: Mar 6, 2026, 6:01 PM EST
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $273.73 million as of March 6, 2026. Its market cap has increased by 56.94% in one year.
Market Cap
273.73M
Enterprise Value
287.74M
1-Year Change
56.94%
Ranking
Category
Stock Price
$4.47
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $273.73M, a decrease of -16.74%. That is a compound annual growth rate of -3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 273.73M | -21.51% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerus | 376.66M |
| Viemed Healthcare | 335.84M |
| RxSight | 315.69M |
| Delcath Systems | 314.11M |
| ClearPoint Neuro | 305.22M |
| Profound Medical | 264.67M |
| Senseonics Holdings | 245.97M |
| CapsoVision | 241.24M |